In This Article
What Kisspeptin Actually Is
Kisspeptin is a peptide hormone produced in your hypothalamus - the part of your brain that controls hormones, appetite, temperature, and sleep. It was originally discovered in 1996 as a tumour suppressor gene (called KiSS-1, named after Hershey's Kisses because the lab was in Hershey, Pennsylvania). It wasn't until 2003 that scientists realised it plays the central role in controlling human reproduction.
Kisspeptin's job is to activate GnRH (gonadotropin-releasing hormone) neurons in your hypothalamus. GnRH then triggers the release of LH (luteinising hormone) and FSH (follicle-stimulating hormone) from your pituitary gland. These hormones control everything: puberty, menstrual cycles, ovulation, testosterone production, sperm development. Kisspeptin sits at the very top of this cascade. It's the master switch.
What It Does In Your Body
- Triggers GnRH release - this is its primary function. A pulse of kisspeptin causes a pulse of GnRH, which causes a pulse of LH and FSH. This cascade controls ovulation in women and testosterone production in men
- Controls the timing of puberty - kisspeptin signalling determines when puberty starts. Mutations in the kisspeptin receptor cause failure to enter puberty
- Regulates menstrual cycles - the natural fluctuations of kisspeptin throughout the cycle help coordinate ovulation timing
- Responds to energy status - kisspeptin links your metabolic state to your reproductive capacity. When you're severely underweight or energy-depleted, kisspeptin drops, which suppresses reproductive function. This is why extreme dieting or overtraining can cause loss of periods in women and low testosterone in men
- Affects sexual arousal and behaviour - brain imaging studies in humans show kisspeptin enhances activity in brain regions associated with sexual arousal and emotional bonding
What The Human Research Shows
Kisspeptin has more clinical trial evidence than most peptides in the reproductive space. The research is centred at Imperial College London, led by Professor Waljit Dhillo's team.
IVF - A Safer Ovulation Trigger
Standard IVF uses hCG (human chorionic gonadotropin) to trigger the final maturation of eggs before collection. The problem: hCG can cause ovarian hyperstimulation syndrome (OHSS) - a potentially dangerous condition where the ovaries swell, fluid leaks into the abdomen, and in severe cases, blood clots can form.
Kisspeptin-54 triggers ovulation through a different pathway - it produces a more natural LH surge that closely mimics what happens in a normal menstrual cycle. Clinical trials published in the Journal of Clinical Investigation showed kisspeptin-54 successfully triggered egg maturation in IVF patients with zero cases of OHSS. Pregnancy rates ranged from 23-37% across randomised trials.
MVT-602 - The Next-Generation Version (2024)
MVT-602 is a kisspeptin analogue designed to last longer in the body. In 2024, two randomised clinical trials in healthy premenopausal women showed that MVT-602 at an intermediate dose produced an LH surge that closely resembles the natural mid-cycle surge - more accurately than any current trigger agent. This triphasic pattern is considered ideal for IVF because it mimics what the body does naturally.
Intranasal Delivery (2025)
A landmark 2025 study published in eBioMedicine (The Lancet family) showed that intranasal kisspeptin-54 - a nasal spray - rapidly stimulated gonadotropin release in both healthy men and women, and in patients with hypothalamic amenorrhoea. No side effects or adverse events. This is significant because it opens the door to a non-injection route of administration, which would be far more practical for clinical use.
Hypothalamic Amenorrhoea
Women who lose their periods due to stress, weight loss, or excessive exercise have suppressed kisspeptin signalling. Studies show that kisspeptin administration can restore LH pulsatility in these patients, potentially restarting menstrual cycles without the need for hormone replacement therapy.
What About Men?
Kisspeptin also affects male reproductive function:
- Stimulates testosterone production - by triggering GnRH and LH, kisspeptin indirectly increases testosterone. Small studies show acute increases in testosterone after kisspeptin administration in men
- Potential for hypogonadism treatment - instead of testosterone replacement (which shuts down natural production and sperm), kisspeptin could stimulate the body's own testosterone production while preserving fertility. This is particularly relevant for men wanting to maintain sperm production
- Brain effects - brain imaging studies show kisspeptin enhances limbic brain activity in men, affecting sexual arousal and partner-related brain processing
Why This Matters Beyond Fertility Clinics
Kisspeptin's role as the link between metabolic health and reproductive function has broader implications:
- PCOS (Polycystic Ovary Syndrome) - kisspeptin signalling is altered in PCOS. Understanding and modulating this could lead to better treatments
- Metabolic syndrome - the kisspeptin-metabolism connection means it could play a role in managing metabolic conditions that affect hormones
- Ageing - reproductive hormone decline with age (menopause, andropause) involves kisspeptin neuron changes. Restoring kisspeptin signalling could potentially modulate age-related hormonal decline
The Honest Bottom Line
Kisspeptin is a genuinely exciting peptide with strong clinical evidence. Unlike most peptides discussed in health optimisation, it has multiple proper human clinical trials, a clear mechanism, and real clinical applications in IVF and reproductive medicine. The 2025 intranasal delivery breakthrough could make it far more accessible. For fertility applications, the evidence is strong and growing. For broader hormonal and anti-ageing applications, the science is promising but earlier-stage. This is one to watch - it's being developed through proper pharmaceutical channels with serious clinical trial programmes.
For the full peptide landscape, read the Complete Peptide Guide.
This article is for educational purposes only. It is not medical advice. Peptides discussed here may not be approved for human use in your country. Always consult a qualified medical professional before making any health decisions.